2013
DOI: 10.1590/0037-868215502013
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: The increased frequency and dissemination of enterobacteria resistant to various antimicrobials is currently worldwide concern. In January 2010, a 94-year-old patient with chronic lymphocytic leukemia was admitted to the University Hospital. This patient died 21 days after hospitalization due to the clinical worsening. Klebsiella pneumoniae producing of extended-spectrum β-lactamases (ESBLs) was isolated of urine culture. This bacterium demonstrated resistance to ceftazidime, ciprofloxacin, levofloxacin, ertap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 11 publications
(8 reference statements)
1
5
0
2
Order By: Relevance
“…These patients had common risk factors, such as prolonged hospitalization, intravenous catheter, previous antimicrobial therapy, and underlying disease. These findings are consistent with previous studies that notified risk factors for acquiring infections with KPC-producing K. pneumoniae 18 . In the present study, all three K. pneumoniae producing KPC were isolated from blood specimens and two of the patients died with septic shock.…”
Section: Resultssupporting
confidence: 93%
“…These patients had common risk factors, such as prolonged hospitalization, intravenous catheter, previous antimicrobial therapy, and underlying disease. These findings are consistent with previous studies that notified risk factors for acquiring infections with KPC-producing K. pneumoniae 18 . In the present study, all three K. pneumoniae producing KPC were isolated from blood specimens and two of the patients died with septic shock.…”
Section: Resultssupporting
confidence: 93%
“…In order to identify the occurrence of CR in HM patients and to understand its epidemiology, we reviewed series and selected case reports that report colonization or infection of HM patients with CR bacteria. These studies were undertaken in different areas of the world, including New York, New Delhi, China, Stockholm, Frankfurt, Roma, Brescia, Athens, Ankara, Cairo, and Haifa in the series studies (Tables 1−3; Cattaneo et al, 2012Cattaneo et al, , 2018Kjellander et al, 2012;Schelenz et al, 2013;Satlin et al, 2013aSatlin et al, , 2016El-Mahallawy et al, 2014;Trecarichi et al, 2015Trecarichi et al, , 2016Wang et al, 2015Wang et al, , 2017Micozzi et al, 2017;Ballo et al, 2019), and in United States, Brazil, Spain, Italy, Poland, Turkey, Israel, Japan, China, and Austria in the case reports (Table 4; Muchtar et al, 2012;Carattoli et al, 2013;Chang et al, 2013;Satlin et al, 2013b;Girmenia et al, 2015;Huang et al, 2015;Kara Leitner et al, 2015;Xing et al, 2015;Kantarcioglu et al, 2016;Tofas et al, 2016;Zhang et al, 2016Zhang et al, , 2018Majewski et al, 2017;Piedra-Carrasco et al, 2017;Asai et al, 2018). When we geolocate the regions that have reported the presence of CR bacteria in HM patients in Figure 1, it can be observed that all these studies have been reported in regions that are either endemic or have a significant increase in carbapenemase enzymes (a coincidence with regions with high levels of CR bacteria) (Figure 1).…”
Section: Carbapenem Resistance In Hematological Patients Vs the Worlmentioning
confidence: 99%
“…After the East coast of the USA, KPC plasmid strains were isolated almost everywhere in the world: in France for the first time in 2005 in a patient coming back from New York where he had undergone bilateral nephrostomy [6]; in Israel [7,8]; in China and Taiwan [9,10]; in South America: in Columbia in a Pseudomonas aeruginosa strain [11], in Brazil [12,13], in Argentina [14]. .…”
Section: Group Of Penicillinases: Kpcmentioning
confidence: 99%